PSPA 26 - Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event

Activity Weighting: Medium

Subcategory Name: Patient Safety and Practice Assessment

Description: A MIPS eligible clinician providing unscheduled care (such as an emergency room, urgent care, or other unplanned encounter) attests that, for greater than 75 percent of case visits that result from a clinically significant adverse drug event, the MIPS eligible clinician provides information, including through the use of health IT to the patients primary care clinician regarding both the unscheduled visit and the nature of the adverse drug event within 48 hours. A clinically significant adverse event is defined as a medication-related harm or injury such as side-effects, supratherapeutic effects, allergic reactions, laboratory abnormalities, or medication errors requiring urgent/emergent evaluation, treatment, or hospitalization.

Supporting Documentation

  • Documentation of an unscheduled clinically significant adverse event, defined as a medication-related harm or injury such as side-effects, supratherapeutic effects, allergic reactions, laboratory abnormalities, or medication errors requiring urgent/emergent evaluation, treatment, or hospitalization. 
  • Documentation of communication of the event to the patient’s primary care clinician within 48 hours of the unscheduled event.
Note
A certified EHR may be used for documentation purposes, but is not required unless attesting for the Promoting Interoperability (formerly ACI) bonus.

Resources

2018 Improvement Activities Requirements

2019 Improvement Activities Requirements

2018 MIPS Improvement Activities Fact Sheet

Scores for Improvement Activities for MIPS APMs in the 2018 Performance Period Fact Sheet

WebChart Documentation
Last Build: Wed, 08 Sep 2021 00:25:58 EDT Legacy Documentation